The addition of gMDSC depletion to CTLA-4 blockade resulted in tumor rejection of all treated MOC1 tumor-bearing mice (Figure 6D), resulting in significantly prolonged survival (Figure 6E). Here, CTLA4 is linked to neoplasm.